Spectrum Asset Management, Inc. Bristol Myers Squibb CO Transaction History

Spectrum Asset Management, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 Apr 16, 2019	SELL	$45.12 - $53.8 $611,330 - $728,936	-13,549 Closed	0 $0
Q4 2018 Jan 28, 2019	SELL	$48.76 - $63.23 $48 - $63	-1 Reduced 0.01%	13,549 $704,000
Q3 2018 Oct 29, 2018	BUY	$55.19 - $62.25 $747,824 - $843,487	13,550 New	13,550 $841,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Spectrum Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Spectrum Asset Management, Inc. with notifications on news.